Teva Archives - Pharmaphorum

Sandoz axes filing of US Rituxan biosimilar

https://pharmaphorum.com/news/sandoz-axes-filing-of-us-rituxan-biosimilar/

Teva slumps after Express Scripts funds migraine rivals in US

https://pharmaphorum.com/news/teva-slumps-after-express-scripts-funds-migraine-rivals-in-us/

Celltrion/Teva Rituxan biosimilar edges closer to US approval

https://pharmaphorum.com/news/celltrion-teva-rituxan-biosimilar-edges-closer-to-us-approval/

Lilly pushes into migraine market as Emgality approved in US

https://pharmaphorum.com/news/lilly-pushes-into-migraine-market-as-emgality-approved-in-us/

FDA approves Teva’s migraine drug, decision due on Lilly’s rival

https://pharmaphorum.com/news/fda-approves-tevas-migraine-drug-decision-due-on-lillys-rival/

Teva holding off launch of opioid addiction drug

https://pharmaphorum.com/news/teva-holding-off-launch-of-opioid-addiction-drug/

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Concerns over Teva migraine drug because of manufacturing issues

https://pharmaphorum.com/news/concerns-over-teva-migraine-drug-because-of-manufacturing-issues/

Remote HCP engagement – still a struggle for life science companies

https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/

Search